Redhill Biopharma
RDHL
#10399
Rank
โ‚ฌ5.11 M
Marketcap
1,00ย โ‚ฌ
Share price
3.04%
Change (1 day)
-83.46%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -705,09ย โ‚ฌ

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -593,25ย โ‚ฌ. In 2017 the company made an earnings per share (EPS) of -2.119ย โ‚ฌ a decrease over its 2016 EPS that were of -1.865ย โ‚ฌ.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-705,09ย โ‚ฌ
2017-2.119ย โ‚ฌ13.64%
2016-1.865ย โ‚ฌ9.12%
2015-1.709ย โ‚ฌ68.01%
2014-1.017ย โ‚ฌ-25.93%
2013-1.373ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
3,14ย โ‚ฌ-100.53%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
6,44ย โ‚ฌ-101.08%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
3,05ย โ‚ฌ-100.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Taro Pharmaceutical
TARO
1,03ย โ‚ฌ-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Teva Pharmaceutical Industries
TEVA
0,53ย โ‚ฌ-100.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel